The DOI matches its Crossref record; 184 of the 192 references it cites were found in a registry or an index; 48 of the 182 sources its claims cite were checked for support.
Global and Multi-National Prevalence of Fungal Diseases-Estimate Precision
Open accessAbstract
Fungal diseases kill more than 1.5 million and affect over a billion people. However, they are still a neglected topic by public health authorities even though most deaths from fungal diseases are avoidable. Serious fungal infections occur as a consequence of other health problems including asthma, AIDS, cancer, organ transplantation and corticosteroid therapies. Early accurate diagnosis allows prompt antifungal therapy; however this is often delayed or unavailable leading to death, serious chronic illness or blindness. Recent global estimates have found 3,000,000 cases of chronic pulmonary aspergillosis, ~223,100 cases of cryptococcal meningitis complicating HIV/AIDS, ~700,000 cases of invasive candidiasis, ~500,000 cases of Pneumocystis jirovecii pneumonia, ~250,000 cases of invasive aspergillosis, ~100,000 cases of disseminated histoplasmosis, over 10,000,000 cases of fungal asthma and ~1,000,000 cases of fungal keratitis occur annually. Since 2013, the Leading International Fungal Education (LIFE) portal has facilitated the estimation of the burden of serious fungal infections country by country for over 5.7 billion people (>80% of the world’s population). These studies have shown differences in the global burden between countries, within regions of the same country and between at risk populations. Here we interrogate the accuracy of these fungal infection burden estimates in the 43 published papers within the LIFE initiative.
Overview
CoChat Summary
TL;DR
This review interrogates the accuracy of global and multi-national estimates of serious fungal disease burden generated through the Leading International Fungal Education (LIFE) initiative. It summarizes estimates from 43 published country reports and highlights wide variation, data gaps, and likely underestimation of fungal disease burden.
Key findings
- Recent global estimates include 3,000,000 cases of chronic pulmonary aspergillosis, ~223,100 cases of cryptococcal meningitis complicating HIV/AIDS, ~700,000 cases of invasive candidiasis, ~500,000 cases of *Pneumocystis jirovecii* pneumonia, ~250,000 cases of invasive aspergillosis, ~100,000 cases of disseminated histoplasmosis, over 10,000,000 cases of fungal asthma, and ~1,000,000 cases of fungal keratitis annually.
- Across LIFE country papers, candidaemia burden was 159,253 cases in 39 countries, invasive aspergillosis was 81,927 cases in 40 countries, and *Pneumocystis jirovecii* pneumonia was 133,487 cases in 40 papers; the highest candidaemia prevalence was reported in Pakistan (38,795 cases, 21 per 100,000).
- Chronic pulmonary aspergillosis estimates were highest in India (209,147) and Nigeria (120,753), with an overall incidence of 22 cases per 100,000 (14.2–30.59 95% CI); ABPA was estimated at 3,550,157 cases and SAFS at 4,125,428 cases across 43 countries.
- Tinea capitis was estimated at 21,073,423 cases in just 16 countries, with Nigeria alone accounting for 15,581,400 cases; global recurrent vulvovaginal candidiasis prevalence was estimated at about 134,000,000 cases.
Methods
- Narrative review of 43 published papers within the LIFE initiative, covering >2000 million people (29% of the world population), with the LIFE portal having facilitated estimates for over 5.7 billion people (>80% of the world’s population).
- The paper describes how country-level burden estimates were derived for specific fungal diseases, using published epidemiological data, modelling assumptions, and at-risk population denominators.
- Main analysis is descriptive and comparative: it aggregates country estimates, examines differences by region, country, and at-risk group, and discusses strengths and weaknesses of the estimation methods.
Limitations
- The paper states that a precise estimate of global prevalence and incidence for each fungal infection remains unknown, and data are scanty in most countries, especially in the developing world.
- It states that knowledge is impaired by lack of regular national surveillance, no obligatory reporting of fungal diseases, poor clinician suspicion outside specialised units, poor diagnostic test performance, and few well-designed published studies; estimates are not intended as a substitute for high-quality epidemiological study or comprehensive surveillance.
- It also states that comparisons across countries are difficult because recent local epidemiological data were available for only some countries, data quality varies, not all institutions report infections, and many low- and low-middle-income countries lack blood culture systems; the text makes evident that country estimates rely on heterogeneous assumptions and uniform rates in places, such as 5 per 100,000 for candidaemia when local data were unavailable and 6% for recurrent vulvovaginal candidiasis.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
33 Valid · 8 Not valid · 70 Not checked · 75 Own results and interpretations
Some cited sources support this claim and some don’t — read each source’s verdict below.
In the paper
“In particular, resistance to fluconazole is common [30,43,44]”
§ Global and Multi-National Prevalence of Fungal Diseases—Estimate Precision > 2. Estimate precision > 2.1. Candidaemia
What the sources say
- Not checked — no full text of the sourcecites [30] Arendrup, 2013, Candida and Candidaemia: Susceptibility and Epidemiology, Dan. Med. J.
- Disputedcites [43] Hii, 2015, Changing epidemiology of candidemia in a medical center in middle Taiwan, J. Microbiol. Immunol. Infect. sourceExperimental — accuracy not yet measured
The Discussion reports an overall fluconazole resistance rate of 4.95% among the clinical Candida isolates, contrary to the unqualified claim that resistance is common. The Antifungal susceptibility section distinguishes resistance from reduced susceptibility: only 4.4% of C. glabrata isolates were resistant, although 66.7% were dose-dependent susceptible. (LLM, conf=0.88)
Checked by a reasoning model — may be wrong.
- Supportedcites [44] Farahat, 2014, Predictors and outcomes of Candida bloodstream infection: Eight-year surveillance, western Saudi Arabia, Int. J. Infect. Dis. source
The Discussion describes a high level of fluconazole resistance as alarming. The Results report low in vitro susceptibility among Candida bloodstream isolates in the hospital studied, supporting the claim in that setting. (LLM, conf=0.90)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Every source the paper cites for this claim was checked and supports it.
In the paper
“Modelling with existing outcome data shows that mortality associated with these priority fungal diseases concurrently with the Joint United Nations Program on HIV/AIDS (UNAIDS) 90-90-90 campaign could save over 1.6 million lives of persons living with HIV globally over the next five years [2].”
§ Global and Multi-National Prevalence of Fungal Diseases—Estimate Precision > 1. Introduction
What the sources say
- Supportedcites [2] Denning, D.W. (2016). Minimizing fungal disease deaths will allow the UNAIDS target of reducing annual AIDS deaths below 500,000 by 2020 to be realized. Philos. Trans. R. Soc. B, 371. source
Split into 2 atoms — 2 confirmed, 0 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
hedgedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“The burden of infectious (all-cause, including fungal) keratitis in Mexico was estimated based on the prevalence of reported in China (0.148%) [150].”
§ Global and Multi-National Prevalence of Fungal Diseases—Estimate Precision > 2. Estimate precision > 2.6. Fungal Keratitis
What the sources say
- Supportedcites [150] Cao, 2014, Prevalence of infectious keratitis in Central China, BMC Ophthalmol. source
The Abstract Results report an infectious keratitis prevalence of 0.148% in Central China and separately include fungal keratitis among its causes. The Mexico estimate is the citing authors’ use of that figure, not a result attributed to this source. (LLM, conf=0.92)
hedgedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Since 2013, the Leading International Fungal Education (LIFE) portal has facilitated the estimation of the burden of serious fungal infections country by country for over 5.7 billion people (>80% of the world’s population).”
§ Global and Multi-National Prevalence of Fungal Diseases—Estimate Precision > Abstract
What the sources say
- Partly supportedcites [14] Denning, 2017, Calling upon all public health mycologists, Eur. J. Clin. Microbiol. Infect. Dis. sourceExperimental — accuracy not yet measured
The paper describes systematic country-by-country estimates of serious fungal infections and links to the LIFE site for completed estimates (p. 1). It does not state that the portal facilitated this work since 2013 or that the estimates covered over 5.7 billion people (>80% of the world’s population); its stated figure of 883 million people refers only to the current 14-country series (p. 1). (LLM, conf=0.84)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“HIV/AIDS pandemic, tuberculosis, chronic obstructive pulmonary disease (COPD), asthma and the increasing incidence of cancers are the major drivers of fungal infections in both developed and developing countries globally [1,2,3,4,5,6].”
§ Global and Multi-National Prevalence of Fungal Diseases—Estimate Precision > 1. Introduction
What the sources say
- Not checked — no full text of the sourcecites [1] Brown, 2012, Hidden Killers: Human Fungal Infections, Sci. Transl. Med. source
- Partly supportedcites [2] Denning, D.W. (2016). Minimizing fungal disease deaths will allow the UNAIDS target of reducing annual AIDS deaths below 500,000 by 2020 to be realized. Philos. Trans. R. Soc. B, 371. sourceExperimental — accuracy not yet measured
The Introduction identifies major fungal diseases complicating HIV, and the section on chronic pulmonary aspergillosis complicating tuberculosis in HIV-positive patients names TB and COPD as underlying pulmonary disorders (page unavailable). The paper does not identify asthma or increasing cancer incidence as drivers, nor does it establish that the listed conditions are the major drivers of fungal infections globally across developed and developing countries. (LLM, conf=0.88)
- Not checked — no full text of the sourcecites [3] Meintjes, 2014, A neglected epidemic: Fungal infections in HIV/AIDS, Trends Microbiol. source
- Not checked — no full text of the sourcecites [4] Guinea, 2010, Pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: Incidence, risk factors, and outcome, Clin. Microbiol. Infect. source
- Not checked — no full text of the sourcecites [5] Marr, 2002, Invasive aspergillosis in allogeneic stem cell transplant recipients: Changes in epidemiology and risk factors, Blood source
- Not checked — no full text of the sourcecites [6] Limper, A.H., Adenis, A., Le, T., and Harrison, T.S. (2017). Fungal infections in HIV/AIDS. Lancet Infect. Dis. source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
52 more claims · 6 with their cited sources checked
Create a free account to see all 186 claims and to verify the 39 references still open.
- Probably not a substantial claim. 80
- It may state two separate claims as one. 82
- The quote only partly states this claim. 1
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Although the target organ of A. fumigatus is the lungs, Aspergillus is known to be angiotropic and has an affinity for host vasculature. As growing hyphae penetrate pulmonary tissues, they can invade the endothelial lining of nearby blood vessels and break off into circulation, causing sepsis and dissemination accompanied by thrombosis, hemorrhagic infarction and invasion of distant organs [8, 164”
From Mechanisms of fungal dissemination (2021) · cites this paper as [8]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Fungal pathogens are responsible for at least 13 million infections and 1.5 million deaths globally per year, primarily in those with some compromised immune function [1].”
From Prevalence and Healthcare Burden of Fungal Infections in the United States, 2018 (2022) · cites this paper as [1]
Experimental — accuracy not yet measuredIn the citing paper
“In healthy individuals, these conidia are rapidly cleared, but in the case of immunocompromised patients, conidia can germinate and develop filamentous hyphae [1, 166]. This fungal growth can result in invasive aspergillosis: a severe and aggressive fungal disease characterized by tissue damage, necrosis and hypoxia [8, 164, 167].”
From Mechanisms of fungal dissemination (2021) · cites this paper as [8]
In the citing paper
“Candida albicans the primary species responsible for mucosal disease”
From Acquisition of cross-azole tolerance and aneuploidy in Candida albicans strains evolved to posaconazole (2022) · cites this paper as Bongomin et al. 2017
In the citing paper
“Deep-seated candidiasis, arising from direct inoculation or hematogenous dissemination of Candida into normally sterile body sites, is often difficult to diagnose and may affect a population as large as that of candidemia [4,5,6].”
From Treatment of Invasive Candidiasis: A Narrative Review (2018) · cites this paper as [4]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Global and Multi-National Prevalence of Fungal Diseases—Estimate Precision > 2. Estimate precision > 2.5. Allergic Bronchopulmonary Aspergillosis (ABPA) & Severe Asthma with Fungal Sensitisation (SAFS)
“28,447 [2.5% of 1,136,092] (62 per 100,000) patients with ABPA”
§ Global and Multi-National Prevalence of Fungal Diseases—Estimate Precision > 2. Estimate precision > 2.5. Allergic Bronchopulmonary Aspergillosis (ABPA) & Severe Asthma with Fungal Sensitisation (SAFS)
“37,491 [3.33% of 1,136,092] (37.5 per 100,000) with severe asthma with fungal sensitisation (SAFS)”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Global and Multi-National Prevalence of Fungal Diseases—Estimate Precision > 2. Estimate precision > 2.5. Allergic Bronchopulmonary Aspergillosis (ABPA) & Severe Asthma with Fungal Sensitisation (SAFS)
“Average incidence is 154 cases per 100,000 (SD ± 654)”
§ Global and Multi-National Prevalence of Fungal Diseases—Estimate Precision > 2. Estimate precision > 2.5. Allergic Bronchopulmonary Aspergillosis (ABPA) & Severe Asthma with Fungal Sensitisation (SAFS)
“the highest incidence rates reported in United Kingdom (654 per 100,000)”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Global and Multi-National Prevalence of Fungal Diseases—Estimate Precision > 2. Estimate precision > 2.1. Candidaemia
“The total burden of candidaemia is 159,253 cases across these 39 countries with available data.”
§ Global and Multi-National Prevalence of Fungal Diseases—Estimate Precision > 2. Estimate precision > 2.1. Candidaemia
“Europe (n = 1 country, 420,549 cases)”
Citations
Cites
Vos, T., Flaxman, A. D., Naghavi, M., Lozano, R., Michaud, C., Ezzati, M., Shibuya, K., Salomon, J. A., Abdalla, S., Aboyans, V., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61729-2 · Cited by 8,291
Wang, H., Naghavi, M., Allen, C., Barber, R. M., Bhutta, Z. A., Carter, A., Casey, D. C., Charlson, F. J., Chen, A. Z., Coates, M. M., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31012-1 · Cited by 6,596
Wisplinghoff, H., Bischoff, T., Tallent, S. M., Seifert, H., Wenzel, R. P., & Edmond, M. B. (2004) · Clinical Infectious Diseases · doi:10.1086/421946 · Cited by 4,496 · cited 1×
“Candidaemia is the most common form of invasive candidiasis associated with an unacceptably high mortality rates in excess of 40% even with the introduction of newer antifungal agents [30,32,33].”
BackgroundHidden Killers: Human Fungal Infections
Brown, G. D., Denning, D. W., Gow, N. A. R., Levitz, S. M., Netea, M. G., & White, T. C. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3004404 · Cited by 4,284 · cited 1×
“Pneumocystis jirovecii pneumonia is emerging as a leading cause of infection in HIV/AIDS patients [1].”
BackgroundSelf-citationGlobal burden of disease of HIV-associated cryptococcal meningitis: an updated analysis
Rajasingham, R., Smith, R. M., Park, B. J., Jarvis, J. N., Govender, N. P., Chiller, T. M., Denning, D. W., Loyse, A., & Boulware, D. R. (2017) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(17)30243-8 · Cited by 1,861 · cited 1×
“[8], Fungal Infection Trust [12], Global Action Fund for Fungal Infection (GAFFI) Roadmap [9], and van de Sande [13].”
BackgroundSelf-citationGlobal asthma prevalence in adults: findings from the cross-sectional world health survey
To, T., Stanojevic, S., Moores, G., Gershon, A. S., Bateman, E. D., Cruz, A. A., & Boulet, L.-P. (2012) · BMC Public Health · doi:10.1186/1471-2458-12-204 · Cited by 1,521 · cited 1×
“6% respectively among individuals aged 18 to 45 years [142].”
BackgroundKullberg, B. J., & Arendrup, M. C. (2015) · New England Journal of Medicine · doi:10.1056/nejmra1315399 · Cited by 1,315 · cited 1×
“Candidaemia is the most common form of invasive candidiasis associated with an unacceptably high mortality rates in excess of 40% even with the introduction of newer antifungal agents [30,32,33].”
BackgroundSobel, J. D. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60917-9 · Cited by 1,270
Marr, K. A., Carter, R. A., Boeckh, M., Martin, P., & Corey, L. (2002) · Blood · doi:10.1182/blood-2002-05-1496 · Cited by 957
(2006) · PubMed · Cited by 906
The clinical spectrum of pulmonary aspergillosis
Kosmidis, C., & Denning, D. W. (2015) · Thorax · doi:10.1136/thoraxjnl-2014-206291 · Cited by 850
Self-citationThe link between fungi and severe asthma: A summary of the evidence
Denning, D. W., O'Driscoll, B. R., Hogaboam, C. M., Bowyer, P., & Niven, R. M. (2006) · European Respiratory Journal · doi:10.1183/09031936.06.00074705 · Cited by 824 · cited 2×
“Asthmatic patients with severe disease (British Thoracic Society step 4 or worse ) who have evidence of sensitized to one or more fungi, by skin prick test or RAST test but do not meet the diagnostic criteria for ABPA (total IgE < 1000 IU/mL) are classified as patients with Severe Asthma with Fung l Sensitization (SAF…”
BackgroundSelf-citationStevens, D. A., Moss, R. B., Kurup, V. P., Knutsen, A. P., Greenberger, P., Judson, M. A., Denning, D. W., Crameri, R., Brody, A. S., Light, M., et al. (2003) · Clinical Infectious Diseases · doi:10.1086/376525 · Cited by 790
Self-citationEpidemiology of nosocomial fungal infections
Fridkin, S. K., & Jarvis, W. R. (1996) · Clinical Microbiology Reviews · doi:10.1128/cmr.9.4.499 · Cited by 782
First hospital outbreak of the globally emerging Candida auris in a European hospital
Schelenz, S., Hagen, F., Rhodes, J. L., Abdolrasouli, A., Chowdhary, A., Hall, A., Ryan, L., Shackleton, J., Trimlett, R., Meis, J. F., et al. (2016) · Antimicrobial Resistance & Infection Control · doi:10.1186/s13756-016-0132-5 · Cited by 768
Clancy, C. J., & Nguyen, M. H. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit006 · Cited by 688
Global trends in the distribution of Candida species causing candidemia
Guinea, J. (2014) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12539 · Cited by 680 · cited 1×
“Candida albicans is the main etiologic Candida species associated with nosocomial invasive candidiasis globally [41].”
BackgroundVulvovaginal candidiasis: Epidemiology, microbiology and risk factors
Gonçalves, B., Ferreira, C., Alves, C. T., Henriques, M., Azeredo, J., & Silva, S. (2016) · Critical Reviews in Microbiology · doi:10.3109/1040841x.2015.1091805 · Cited by 669
Global burden of recurrent vulvovaginal candidiasis: a systematic review
Denning, D. W., Kneale, M., Sobel, J. D., & Rautemaa-Richardson, R. (2018) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(18)30103-8 · Cited by 639 · cited 1×
“The global prevalence of rVVC is estimated at about 134,000,000 cases [18].”
BackgroundSelf-citationChanging epidemiology of systemic fungal infections
Richardson, M., & Lass-Flörl, C. (2008) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2008.01978.x · Cited by 524
Recurrent vulvovaginal candidiasis
Sobel, J. D. (2016) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2015.06.067 · Cited by 502
Denning, D. W., Pleuvry, A., & Cole, D. C. (2013) · Medical Mycology · doi:10.3109/13693786.2012.738312 · Cited by 495
Self-citationLimper, A. H., Adenis, A., Le, T., & Harrison, T. S. (2017) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(17)30303-1 · Cited by 472 · cited 1×
“Mortality of PCP ranges from 10–30% and can be even higher if the diagnosis is delayed [6].”
BackgroundIncidence, characteristics and outcome of ICU-acquired candidemia in India
Chakrabarti, A., Sood, P., Rudramurthy, S. M., Chen, S., Kaur, H., Capoor, M., Chhina, D., Rao, R., Eshwara, V. K., Xess, I., et al. (2015) · Intensive Care Medicine · doi:10.1007/s00134-014-3603-2 · Cited by 454
Gopinathan, U., Garg, P., Fernandes, M., Sharma, S., Athmanathan, S., & Rao, G. N. (2002) · Cornea · doi:10.1097/00003226-200208000-00004 · Cited by 452
Underlying conditions in chronic pulmonary aspergillosis including simple aspergilloma
Smith, N. L., & Denning, D. W. (2011) · European Respiratory Journal · doi:10.1183/09031936.00054810 · Cited by 449 · cited 1×
“; post-tuberculous cases probably represent 50% (range 20–85%) [134] of the total CPA caseload, therefore the estimated cases of CPA in Nigeria was (60,377 × 2) = 120,754.”
BackgroundSelf-citationGlobal burden of chronic pulmonary aspergillosis as a sequel to pulmonary tuberculosis
Denning, D., Pleuvry, A., & Cole, D. (2011) · Bulletin of the World Health Organization · doi:10.2471/blt.11.089441 · Cited by 420
Guinea, J., Torres-Narbona, M., Gijón, P., Muñoz, P., Pozo, F., Peláez, T., de Miguel, J., & Bouza, E. (2010) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2009.03015.x · Cited by 397 · cited 12×
“The lack of data on COPD admission to hospital is a limiting factor, although published for several countries [116,117].”
BackgroundInfluentialPCR Diagnosis of Invasive Candidiasis: Systematic Review and Meta-Analysis
Avni, T., Leibovici, L., & Paul, M. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.01602-10 · Cited by 389
Epidemiology of invasive candidiasis
Arendrup, M. C. (2010) · Current Opinion in Critical Care · doi:10.1097/mcc.0b013e32833e84d2 · Cited by 376 · cited 1×
“Comparisons of the incidence across countries is difficult as recent local epidemiological data was only available for 20 of the countries and the others used an incidence of 5 per 100,000 cases for their estimations [46].”
BackgroundGlobal Burden of Human Mycetoma: A Systematic Review and Meta-analysis
van de Sande, W. W. J. (2013) · PLoS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0002550 · Cited by 369 · cited 2×
“[8], Fungal Infection Trust [12], Global Action Fund for Fungal Infection (GAFFI) Roadmap [9], and van de Sande [13].”
BackgroundQueiroz-Telles, F., de Hoog, S., Santos, D. W. C. L., Salgado, C. G., Vicente, V. A., Bonifaz, A., Roilides, E., Xi, L., Azevedo, C. D. M. P. E. S., da Silva, M. B., et al. (2017) · Clinical Microbiology Reviews · doi:10.1128/cmr.00032-16 · Cited by 360
Fungal allergy in asthma-state of the art and research needs
Denning, D. W., Pashley, C., Hartl, D., Wardlaw, A., Godet, C., Del Giacco, S., Delhaes, L., & Sergejeva, S. (2014) · Clinical and Translational Allergy · doi:10.1186/2045-7022-4-14 · Cited by 357 · cited 2×
“The major assumptions made were based on previous studies of SAFS and ABPA; Severe asthma is thought to affect about 10% of adults and in other countries, 33–70% are sensitised to fungi [137] and that 2.”
BackgroundMethodSelf-citationMycetoma: a unique neglected tropical disease
Zijlstra, E. E., van de Sande, W. W. J., Welsh, O., Mahgoub, E. S., Goodfellow, M., & Fahal, A. H. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(15)00359-x · Cited by 346
Ullmann, A. J., Akova, M., Herbrecht, R., Viscoli, C., Arendrup, M. C., Arikan-Akdagli, S., Bassetti, M., Bille, J., Calandra, T., Castagnola, E., et al. (2012) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12041 · Cited by 334
Upadhyay, M. P., Karmacharya, P. C. D., Koirala, S., Tuladhar, N. R., Bryan, L. E., Smolin, G., & Whitcher, J. P. (1991) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(14)76903-x · Cited by 329
Allergic Bronchopulmonary Aspergillosis: Staging as an Aid to Management
PATTERSON, R., GREENBERGER, P. A., RADIN, R. C., & ROBERTS, M. (1982) · Annals of Internal Medicine · doi:10.7326/0003-4819-96-3-286 · Cited by 327 · cited 1×
“Clinical symptoms include poorly controlled asthma, haemoptysis, fever and expectoration of mucus plugs [138,139].”
BackgroundA neglected epidemic: Fungal infections in HIV/AIDS
Armstrong-James, D., Meintjes, G., & Brown, G. D. (2014) · Trends in Microbiology · doi:10.1016/j.tim.2014.01.001 · Cited by 325 · cited 1×
“Global prevalence is thought to be higher than 400,000 annually cases worldwide [3].”
BackgroundFactors associated with mortality in transplant patients with invasive aspergillosis
Baddley, J. W., Andes, D. R., Marr, K. A., Kontoyiannis, D. P., Alexander, B. D., Kauffman, C. A., Oster, R. A., Anaissie, E. J., Walsh, T. J., Schuster, M. G., et al. (2010) · Clinical Infectious Diseases · doi:10.1086/652768 · Cited by 303 · cited 1×
“The global incidence of invasive aspergillosis was previously reported to be 200,000 cases with an associated mortality ranging from 30–80% [108], recently updated to >300,000 cases [20].”
BackgroundBerenguer, J., Buck, M., Witebsky, F., Stock, F., Pizzo, P. A., & Walsh, T. J. (1993) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/0732-8893(93)90020-8 · Cited by 290
Hay, R. J. (2017) · Mycopathologia · doi:10.1007/s11046-016-0058-8 · Cited by 277 · cited 15×
“Its clinical manifestations range from mild scaling with little hair loss to large inflammatory and pustular plaques with extensive alopecia [173].”
BackgroundInfluentialIncidence of Ulcerative Keratitis in a Defined Population From 1950 Through 1988
Erie, J. C. (1993) · Archives of Ophthalmology · doi:10.1001/archopht.1993.01090120087027 · Cited by 268
Foxman, B., Muraglia, R., Dietz, J.-P., Sobel, J. D., & Wagner, J. (2013) · Journal of Lower Genital Tract Disease · doi:10.1097/lgt.0b013e318273e8cf · Cited by 261
O'Driscoll, B. R., Hopkinson, L. C., & Denning, D. W. (2005) · BMC Pulmonary Medicine · doi:10.1186/1471-2466-5-4 · Cited by 254
Self-citationInvasive fungal infections in solid organ transplant recipients
Gavaldà, J., Meije, Y., Fortún, J., Roilides, E., Saliba, F., Lortholary, O., Muñoz, P., Grossi, P., & Cuenca-Estrella, M. (2014) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12660 · Cited by 232
Cooley, L., Dendle, C., Wolf, J., Teh, B. W., Chen, S. C., Boutlis, C., & Thursky, K. A. (2014) · Internal Medicine Journal · doi:10.1111/imj.12599 · Cited by 228
Arendrup, M. C., Dzajic, E., Jensen, R. H., Johansen, H. K., Kjaldgaard, P., Knudsen, J. D., Kristensen, L., Leitz, C., Lemming, L. E., Nielsen, L., et al. (2013) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12212 · Cited by 206 · cited 1×
“In particular, resistance to fluconazole is common [30,43,44] which is important as it is the most commonly used antifungal agent for prophylaxis and treatment of Candida infections in many parts of the world [45].”
BackgroundIncidence of corneal ulceration in Madurai district, South India
Gonzales, C. A., Srinivasan, M., Whitcher, J. P., & Smolin, G. (1996) · Ophthalmic Epidemiology · doi:10.3109/09286589609080122 · Cited by 202
Predictors of mortality in chronic pulmonary aspergillosis
Lowes, D., Al-Shair, K., Newton, P. J., Morris, J., Harris, C., Rautemaa-Richardson, R., & Denning, D. W. (2017) · European Respiratory Journal · doi:10.1183/13993003.01062-2016 · Cited by 194 · cited 1×
“In a cohort of 387 CPA patients referred to the UK’s National Aspergillosis Centre from 1992 to June 2012, survival was 86%, 62% and 47% at 1, 5 and 10 years, respectively [135].”
BackgroundSelf-citationHIV-Associated Pneumocystis Pneumonia
Huang, L., Cattamanchi, A., Davis, J. L., Boon, S. D., Kovacs, J., Meshnick, S., Miller, R. F., Walzer, P. D., Worodria, W., & Masur, H. (2011) · Proceedings of the American Thoracic Society · doi:10.1513/pats.201009-062wr · Cited by 191
Severe asthma with fungal sensitization
Agarwal, R. (2011) · Current Allergy and Asthma Reports · doi:10.1007/s11882-011-0217-4 · Cited by 188 · cited 1×
“5 million asthma related deaths worldwide [148,149].”
Global burden of chronic pulmonary aspergillosis complicating sarcoidosis
Denning, D. W., Pleuvry, A., & Cole, D. C. (2013) · European Respiratory Journal · doi:10.1183/09031936.00226911 · Cited by 180
Self-citationOne year prospective survey of Candida bloodstream infections in Scotland
Odds, F. C., Hanson, M. F., Davidson, A. D., Jacobsen, M. D., Wright, P., Whyte, J. A., Gow, N. A. R., & Jones, B. L. (2007) · Journal of Medical Microbiology · doi:10.1099/jmm.0.47239-0 · Cited by 176 · cited 1×
“8 cases per 100,000 population per year shortly after the millennium, 254 bloodstream and 669 invasive Candida cases annually [27].”
BackgroundLim, S., Lam, D. C.-L., Muttalif, A. R., Yunus, F., Wongtim, S., Lan, L. T. T., Shetty, V., Chu, R., Zheng, J., Perng, D.-W., et al. (2015) · Asia Pacific Family Medicine · doi:10.1186/s12930-015-0020-9 · Cited by 167 · cited 1×
“The lack of data on COPD admission to hospital is a limiting factor, although published for several countries [116,117].”
BackgroundO'Driscoll, B. R., Powell, G., Chew, F., Niven, R. M., Miles, J. F., Vyas, A., & Denning, D. W. (2009) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2009.03339.x · Cited by 166 · cited 2×
“leads to increased severity, more exacerbations and a higher mortality [146,147].”
BackgroundSelf-citationThe burden of serious human fungal infections in Brazil
Giacomazzi, J., Baethgen, L., Carneiro, L. C., Millington, M. A., Denning, D. W., Colombo, A. L., Pasqualotto, A. C., & in association with the LIFE program (2016) · Mycoses · doi:10.1111/myc.12427 · Cited by 164
Self-citationChanging epidemiology of candidaemia in Australia
Chapman, B., Slavin, M., Marriott, D., Halliday, C., Kidd, S., Arthur, I., Bak, N., Heath, C. H., Kennedy, K., Morrissey, C. O., et al. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkw422 · Cited by 163
Aspergillus infection in lung transplant patients: incidence and prognosis
Iversen, M., Burton, C. M., Vand, S., Skovfoged, L., Carlsen, J., Milman, N. T., Andersen, C. B., Rasmussen, M., & Tvede, M. (2007) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-007-0376-3 · Cited by 154
Intra-Abdominal Candidiasis: The Importance of Early Source Control and Antifungal Treatment
Vergidis, P., Clancy, C. J., Shields, R. K., Park, S. Y., Wildfeuer, B. N., Simmons, R. L., & Nguyen, M. H. (2016) · PLOS ONE · doi:10.1371/journal.pone.0153247 · Cited by 150
(2013) · PubMed · Cited by 150
Changing epidemiology of candidaemia in Australia
Chapman, B., Slavin, M., Marriott, D., Halliday, C., Kidd, S., Arthur, I., Bak, N., Heath, C. H., Kennedy, K., Morrissey, C. O., et al. (2017) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx047 · Cited by 149
Risk stratification for invasive aspergillosis in immunocompromised patients
Herbrecht, R., Bories, P., Moulin, J., Ledoux, M., & Letscher‐Bru, V. (2012) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2012.06829.x · Cited by 148
Pneumocystis pneumonia suspected cases in 604 non-HIV and HIV patients
Bienvenu, A.-L., Traore, K., Plekhanova, I., Bouchrik, M., Bossard, C., & Picot, S. (2016) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2016.03.018 · Cited by 141 · cited 1×
“In addition, the increasing use of immunosuppressant drugs, their use in high doses or their combination has increased numbers of PCP cases in patients with solid tumours, haematological malignancies, rheumatic diseases or organ transplant recipients [128,129].”
BackgroundTwelve-year analysis of microbial keratitis trends at a UK tertiary hospital
Tan, S. Z., Walkden, A., Au, L., Fullwood, C., Hamilton, A., Qamruddin, A., Armstrong, M., Brahma, A. K., & Carley, F. (2017) · Eye · doi:10.1038/eye.2017.55 · Cited by 136
Invasive Candida species infections: a 5 year population-based assessment
Laupland, K. B., Gregson, D. B., Church, D. L., Ross, T., & Elsayed, S. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki258 · Cited by 130
Mycobacterial infections in solid organ transplant recipients
Meije, Y., Piersimoni, C., Torre-Cisneros, J., Dilektasli, A. G., & Aguado, J. M. (2014) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12641 · Cited by 124
Tasaka, S., & Tokuda, H. (2012) · Journal of Infection and Chemotherapy · doi:10.1007/s10156-012-0453-0 · Cited by 123 · cited 2×
“In addition, the increasing use of immunosuppressant drugs, their use in high doses or their combination has increased numbers of PCP cases in patients with solid tumours, haematological malignancies, rheumatic diseases or organ transplant recipients [128,129].”
BackgroundMethodEstimation of the Burden of Chronic and Allergic Pulmonary Aspergillosis in India
Agarwal, R., Denning, D. W., & Chakrabarti, A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0114745 · Cited by 121 · cited 5×
“5% of asthma India [136] 1,380,000 114 2.”
BackgroundInfluentialSelf-citationMulti-Country Estimate of Different Manifestations of Aspergillosis in Cystic Fibrosis
Armstead, J., Morris, J., & Denning, D. W. (2014) · PLoS ONE · doi:10.1371/journal.pone.0098502 · Cited by 121
Self-citationDenning, D. W. (2016) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2015.0468 · Cited by 117 · cited 2×
“6 million lives of persons living with HIV globally over the next five years [2].”
BackgroundSelf-citationGamaletsou, M. N., Walsh, T. J., Zaoutis, T., Pagoni, M., Kotsopoulou, M., Voulgarelis, M., Panayiotidis, P., Vassilakopoulos, T., Angelopoulou, M. K., Marangos, M., et al. (2014) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12312 · Cited by 112
Estimating the burden of invasive and serious fungal disease in the United Kingdom
Pegorie, M., Denning, D. W., & Welfare, W. (2017) · Journal of Infection · doi:10.1016/j.jinf.2016.10.005 · Cited by 104 · cited 6×
“United Kingdom [19] 413,724 654 Trinidad and Tobago [79] 4608 344 Dominican Republic [69] 33,197 329 Ecuador [70] 45,183 311 Brazil [52] 599,283 288 Belgium [66] 30,402 273 Greece [72] 27,744 256 Jamaica [74] 6753 248 Egypt [71] 176,661 214”
BackgroundResultInfluentialSelf-citationVazquez, J. A., & Sobel, J. D. (2002) · Infectious Disease Clinics of North America · doi:10.1016/s0891-5520(02)00042-9 · Cited by 104
Incidence and clinical characteristics of fungal keratitis in a D anish population from 2000 to 2013
Nielsen, S. E., Nielsen, E., Julian, H. O., Lindegaard, J., Højgaard-Olsen, K., Ivarsen, A., Hjortdal, J., & Heegaard, S. (2014) · Acta Ophthalmologica · doi:10.1111/aos.12440 · Cited by 104
Zaoutis, T. E. (2010) · Current Medical Research and Opinion · doi:10.1185/03007995.2010.487796 · Cited by 102
Invasive aspergillosis in patients with liver disease
Falcone, M., Massetti, A. P., Russo, A., Vullo, V., & Venditti, M. (2010) · Medical Mycology · doi:10.3109/13693786.2010.535030 · Cited by 100 · cited 1×
“Other lower risk patients include those with COPD [4], high dose corticosteroid treatment [101], lung cancer [102], liver cirrhosis [103,104], renal and liver transplantation [105], diabetes mellitus [106] and sepsis, especially in the ICU setting [107].”
BackgroundDermatophytes and dermatophytosis in the eastern and southern parts of Africa
Nweze, E. I., & Eke, I. E. (2018) · Medical Mycology · doi:10.1093/mmy/myx025 · Cited by 100 · cited 1×
“Tinea capitis is a common superficial infection of the scalp hair caused by dermatophyte fungi; occurring predominantly in children [172,173].”
BackgroundAn estimation of burden of serious fungal infections in France
Gangneux, J., Bougnoux, M., Hennequin, C., Godet, C., Chandenier, J., Denning, D. W., & Dupont, B. (2016) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2016.11.001 · Cited by 97
Self-citationXu, H., Li, L., Huang, W.-J., Wang, L.-X., Li, W.-F., & Yuan, W.-F. (2012) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03503.x · Cited by 95
Yan, X., Li, M., Jiang, M., Zou, L., Luo, F., & Jiang, Y. (2009) · Cancer · doi:10.1002/cncr.24559 · Cited by 94
Moto, J. N., Maingi, J. M., & Nyamache, A. K. (2015) · BMC Research Notes · doi:10.1186/s13104-015-1240-7 · Cited by 93
Strategies to Reduce Mortality in Adult and Neonatal Candidemia in Developing Countries
Kaur, H., & Chakrabarti, A. (2017) · Journal of Fungi · doi:10.3390/jof3030041 · Cited by 93
Satimia, F. T., McBride, S. R., & LEPPARD, B. J. (1998) · Archives of Dermatology · doi:10.1001/archderm.134.11.1363 · Cited by 92
Clinical outcomes of keratitis
Green, M. D., Apel, A. J., Naduvilath, T., & Stapleton, F. J. (2007) · Clinical & Experimental Ophthalmology · doi:10.1111/j.1442-9071.2007.01511.x · Cited by 92 · cited 1×
“Mycotic keratitis remains a serious cause of corneal opacification and vision loss [153], with an estimated global burden of about 1–1.”
BackgroundPrevalence of infectious keratitis in Central China
Cao, J., Yang, Y., Yang, W., Wu, R., Xiao, X., Yuan, J., Xing, Y., & Tan, X. (2014) · BMC Ophthalmology · doi:10.1186/1471-2415-14-43 · Cited by 88 · cited 2×
“15% of general population based on the Chinese study [150] Thailand [55] 9765 15.”
BackgroundPrevalence of dermatophytosis among primary school children in Oke-oyi community of Kwara state
Adefemi, S., Odeigah, L., & Alabi, K. (2011) · Nigerian Journal of Clinical Practice · doi:10.4103/1119-3077.79235 · Cited by 88
The spectrum of dermatological disorders among primary school children in Dar es Salaam
Komba, E. V., & Mgonda, Y. M. (2010) · BMC Public Health · doi:10.1186/1471-2458-10-765 · Cited by 86
Oke, O. O., Onayemi, O., Olasode, O. A., Omisore, A. G., & Oninla, O. A. (2014) · Dermatology Research and Practice · doi:10.1155/2014/842917 · Cited by 80
Epidemiology and disease burden from allergic disease in Scotland: analyses of national databases
Anandan, C., Gupta, R., Simpson, C., Fischbacher, C., & Sheikh, A. (2009) · Journal of the Royal Society of Medicine · doi:10.1258/jrsm.2009.090027 · Cited by 78 · cited 1×
“The lifetime prevalence of asthma increases with age, a Scottish study reported asthma point prevalence of 20% in boys and 12% in girls under 16 years with a corresponding lifetime prevalence of 29% and 20% respectively [143].”
Skin diseases among schoolchildren in Ghana, Gabon, and Rwanda
Hogewoning, A., Amoah, A., Bavinck, J. N. B., Boakye, D., Yazdanbakhsh, M., Adegnika, A., De Smedt, S., Fonteyne, Y., Willemze, R., & Lavrijsen, A. (2013) · International Journal of Dermatology · doi:10.1111/j.1365-4632.2012.05822.x · Cited by 75
Nosocomial candidaemia in children: results of a 9‐year study
Çelebi, S., HACIMUSTAFAOĞLU, M. K., Özdemır, Ö., & Özkaya, G. (2007) · Mycoses · doi:10.1111/j.1439-0507.2007.01464.x · Cited by 73
Pneumocystis Pneumonia: Current Concepts in Pathogenesis, Diagnosis, and Treatment
Krajicek, B. J., Thomas, C. F., & Limper, A. H. (2009) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2009.02.005 · Cited by 73
Serious fungal infections in Pakistan
Jabeen, K., Farooqi, J. Q., Mirza, S., Denning, D. W., & Zafar, A. (2017) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-017-2919-6 · Cited by 73 · cited 8×
“2 Nigeria [62] 120,747 78 Philippines [93] 77,172 78 Pakistan [53] 72,438 70 Vietnam [120] 55,509 61 Dominican Republic [69] 1374 55 Uganda [122] 18,000 46 Bangladesh [65] 20,720 41 Kenya [75] 12,927 32 Thailand [55] 19,044 29.”
BackgroundInfluentialSelf-citationFaria‐Ramos, I., Neves-Maia, J., Ricardo, E., Santos‐Antunes, J., Silva, A. P., Costa‐de‐Oliveira, S., Cantón, R., Rodrigues, A. G., & Pina‐Vaz, C. (2014) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-014-2194-8 · Cited by 69 · cited 1×
“2 Data from Portuguese multicentre survey [92] Philippines [93] 1968 2 2 per 100,000 + 50% candida peritonitis”
BackgroundBurden of serious fungal infections in Spain
Rodriguez-Tudela, J. L., Alastruey‐Izquierdo, A., Gago, S., Cuenca‐Estrella, M., León, C., Miró, J. M., Boluda, A. N., Ruíz-Camps, I., Solé, A., & Denning, D. W. (2014) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2014.07.013 · Cited by 68 · cited 6×
“Two studies have documented the rate of IA detected by culture in patients admitted to hospital with IA: Guinea et al. [4] in Spain and Xu et al. [109] in southern China.”
BackgroundInfluentialSelf-citationThe ambitious '95-95 by 2025' roadmap for the diagnosis and management of fungal diseases
Denning, D. W. (2015) · Thorax · doi:10.1136/thoraxjnl-2015-207305 · Cited by 67 · cited 3×
“[8], Fungal Infection Trust [12], Global Action Fund for Fungal Infection (GAFFI) Roadmap [9], and van de Sande [13].”
BackgroundSelf-citationCalling upon all public health mycologists: To accompany the country burden papers from 14 countries
Denning, D. W. (2017) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-017-2909-8 · Cited by 67 · cited 1×
“7 billion people (>80% of the world’s population) (Figure 1) [14].”
Self-citationDermatophytosis among Schoolchildren in Three Eco-climatic Zones of Mali
Coulibaly, O., Kone, A. K., Doumbo, S., Goïta, S., Gaudart, J., DJIMDÉ, A. A., Piarroux, R., Doumbo, O. K., Thera, M. A., & Ranque, S. (2016) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0004675 · Cited by 65
St‐Germain, G., Laverdière, M., Pelletier, R., René, P., Bourgault, A., Lemieux, C., & Libman, M. (2007) · Canadian Journal of Infectious Diseases and Medical Microbiology · doi:10.1155/2008/634046 · Cited by 62
Burden of serious fungal infection in Nigeria.
(2014) · PubMed · Cited by 62
Self-citationAl Thaqafi, A. H. O., Farahat, F. M., Al Harbi, M. I., Al Amri, A. F. W., & Perfect, J. R. (2014) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2013.12.012 · Cited by 60 · cited 1×
“In particular, resistance to fluconazole is common [30,43,44] which is important as it is the most commonly used antifungal agent for prophylaxis and treatment of Candida infections in many parts of the world [45].”
BackgroundAntibiotic Prescription for COPD Exacerbations Admitted to Hospital: European COPD Audit
López-Campos, J. L., Hartl, S., Pozo-Rodriguez, F., Roberts, C. M., & on behalf of the European COPD Audit team (2015) · PLOS ONE · doi:10.1371/journal.pone.0124374 · Cited by 59 · cited 1×
“In Europe, there are 1,100,000 COPD admissions annually, possibly contributing 14,300–42,900 IA cases [112].”
BackgroundTrends in COPD mortality and hospitalizations in countries and regions of Asia-Pacific
TAN, W. C., SEALE, P., IP, M., SHIM, Y., CHIANG, C., NG, T., ABISHEGANADAN, J., CHAROENRATANAKUL, S., DeGUIA, T., MAHAYIDDIN, A., et al. (2009) · Respirology · doi:10.1111/j.1440-1843.2008.01415.x · Cited by 58 · cited 11×
“The lack of data on COPD admission to hospital is a limiting factor, although published for several countries [116,117].”
BackgroundInfluentialGeographic differences in clinical characteristics and management of COPD: The EPOCA study
Miravitlles, M. (2008) · International Journal of Chronic Obstructive Pulmonary Disease · doi:10.2147/copd.s4257 · Cited by 58 · cited 1×
“The lack of data on COPD admission to hospital is a limiting factor, although published for several countries [116,117].”
BackgroundClinical use of cerebral oximetry in extremely preterm infants is feasible
Hyttel-Sørensen, S., Austin, T., van Bel, F., Benders, M. J. N. L., Claris, O., Dempsey, E. M., Fumagalli, M., Gluud, C., Hagmann, C. F., Hellström-Westas, L. K., et al. (2013) · PubMed · doi:10.5167/uzh-79553 · Cited by 58
Eziyi Iche, K. A. L. U., Wagbatsoma, V. A., Ogbaini-Emovon, E., Nwadike, V. U., & Ojide, C. K. (2015) · Pan African Medical Journal · doi:10.11604/pamj.2015.20.182.6069 · Cited by 57
Changing epidemiology of candidemia in a medical center in middle Taiwan
Hii, I.-M., Chang, H.-L., Lin, L.-C., Lee, Y.-L., Liu, Y.-M., Liu, C.-E., Chen, C.-H., Cheng, Y.-R., & Chang, C.-Y. (2015) · Journal of Microbiology, Immunology and Infection · doi:10.1016/j.jmii.2013.08.017 · Cited by 56 · cited 1×
“In particular, resistance to fluconazole is common [30,43,44] which is important as it is the most commonly used antifungal agent for prophylaxis and treatment of Candida infections in many parts of the world [45].”
BackgroundTinea capitis among primary school children in some parts of central Nigeria
Ayanbimpe, G. M., Taghir, H., Diya, A., & Wapwera, S. D. (2008) · Mycoses · doi:10.1111/j.1439-0507.2007.01476.x · Cited by 56
Burden of fungal infections in Qatar
Taj‐Aldeen, S. J., Chandra, P., & Denning, D. W. (2015) · Mycoses · doi:10.1111/myc.12386 · Cited by 54 · cited 5×
“6 per 100,000 + 50% of candida peritonitis Qatar [54] 288 15.”
BackgroundInfluentialSelf-citationWu, Z., Liu, Y., Feng, X., Liu, Y., Wang, S., Zhu, X., Chen, Q., & Pan, S. (2014) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2013.11.011 · Cited by 54 · cited 9×
“Some estimates have also included IA complicating lung cancer, estimated from one large study in China at 2.6% [102].”
BackgroundInfluentialChen, P., Chuang, Y., Wang, J., Sheng, W., Yu, C., Chu, C.-C., Hsueh, P., Chang, S., & Chen, Y. (2012) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2012.08.025 · Cited by 54
AL-MOBEIREEK, A. F., GAD. EL-RAB, M. O., AL-HEDAITHY, S. S. A., ALASALI, K., AL-MAJED, S., & JOHARJY, I. (2001) · Respiratory Medicine · doi:10.1053/rmed.2001.1047 · Cited by 53 · cited 1×
“They may develop progressive lung damage, respiratory failure and eventually death [140].”
BackgroundTinea capitis among primary school children in Anambra state of Nigeria
Emele, F. E., & Oyeka, C. A. (2008) · Mycoses · doi:10.1111/j.1439-0507.2008.01507.x · Cited by 51
Kieliger, S., Glatz, M., Cozzio, A., & Bosshard, P. P. (2015) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.12908 · Cited by 51 · cited 1×
“it was brought under effective control following the introduction of griseofulvin and concerted public health interventions [173,174].”
BackgroundSmith, R. M., Nguyen, T. A., Ha, H. T. T., Thắng, P. H., Thuy, C., Lien, T. X., Bui, H. T., Le, T. H., Struminger, B. B., McConnell, M. S., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062213 · Cited by 50 · cited 9×
“81,927 cases of invasive aspergillosis have been observed with the maximum number of cases in Vietnam (14,523 cases a year) [115] and the minimum number of cases in Trinidad and Tobago (8 cases a year) [79].”
BackgroundInfluentialSerious fungal infections in Canada
Dufresne, S. F., Cole, D. C., Denning, D. W., & Sheppard, D. C. (2017) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-017-2922-y · Cited by 50 · cited 5×
“United Kingdom [19] 413,724 654 Trinidad and Tobago [79] 4608 344 Dominican Republic [69] 33,197 329 Ecuador [70] 45,183 311 Brazil [52] 599,283 288 Belgium [66] 30,402 273 Greece [72] 27,744 256 Jamaica [74] 6753 248 Egypt [71] 176,661 214 Canada [86] 73,344 206 Asthmatic patients with severe disease (British Thoraci…”
BackgroundInfluentialSelf-citationParkes‐Ratanshi, R., Achan, B., Kwizera, R., Kambugu, A., Meya, D., & Denning, D. W. (2015) · Mycoses · doi:10.1111/myc.12387 · Cited by 49
Self-citationThe burden of serious fungal diseases in Russia
Климко, Н. Н., Kozlova, Y. I., Khostelidi, S. N., Витальевна, Ш. О., Borzova, Y., Burygina, E. V., Vasilyeva, N. V., & Denning, D. W. (2015) · Mycoses · doi:10.1111/myc.12388 · Cited by 49 · cited 6×
“Country (Reference) Burden Rate/100,000 Russia [59] 52,311 126.”
BackgroundInfluentialSelf-citationBurden of serious fungal infections in Mexico
Corzo-León, D., Armstrong-James, D. P. H., & Denning, D. W. (2015) · Mycoses · doi:10.1111/myc.12395 · Cited by 49 · cited 6×
“00 40% of microbial keratitis Mexico [76] 11,638 10.”
BackgroundInfluentialSelf-citationAetiology of tinea capitis in school children
Ayaya, S., Kamar, K. K., & Kakai, R. (2001) · East African Medical Journal · doi:10.4314/eamj.v78i10.8963 · Cited by 48
Levallois, J., Nadeau-Fredette, A.-C., Labbé, A.-C., Laverdière, M., Ouimet, D., & Vallée, M. (2012) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2011.09.016 · Cited by 47
Dermatophyte Infections In Primary School Children In Kibera Slums Of Nairobi
Chepchirchir, A., Bii, C. C., & Ndinya–Achola, J. (2009) · East African Medical Journal · doi:10.4314/eamj.v86i2.46934 · Cited by 46
Queratomicosis en un centro de atención oftalmológica en la Ciudad de México
Vanzzini Zago, V., Manzano-Gayosso, P., Hernández-Hernández, F., Méndez-Tovar, L. J., Gómez-Leal, A., & López Martínez, R. (2010) · Revista Iberoamericana de Micología · doi:10.1016/j.riam.2009.09.003 · Cited by 45
Prevalence of Tinea Capitis among School Children in Nok Community of Kaduna State, Nigeria
Dogo, J., Afegbua, S. L., & Dung, E. C. (2016) · Journal of Pathogens · doi:10.1155/2016/9601717 · Cited by 45
Serious fungal infections in Egypt
ZAKI, S. M., & Denning, D. W. (2017) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-017-2929-4 · Cited by 45 · cited 7×
“00 15% of microbial keratitis Egypt [71] 11,550 14.”
BackgroundInfluentialSelf-citationEpidemiology of tinea capitis among school-age children in Meiganga, Cameroon
Kechia, F. A., Kouoto, E. A., Nkoa, T., et al. (2014) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2013.12.002 · Cited by 44
Tinea capitis in schoolchildren in southern I vory C oast
Kassi, K. F., Abibatou, K., Djohan, V., Bosson-Vanga, H., Etienne, A. K., Kiki‐Barro, P. C., Yavo, W., Koné, M., & Menan, E. I. H. (2013) · International Journal of Dermatology · doi:10.1111/j.1365-4632.2012.05733.x · Cited by 43
Serious fungal infections in Thailand
Chayakulkeeree, M., & Denning, D. W. (2017) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-017-2927-6 · Cited by 43 · cited 8×
“2 Nigeria [62] 120,747 78 Philippines [93] 77,172 78 Pakistan [53] 72,438 70 Vietnam [120] 55,509 61 Dominican Republic [69] 1374 55 Uganda [122] 18,000 46 Bangladesh [65] 20,720 41 Kenya [75] 12,927 32 Thailand [55] 19,044 29.”
BackgroundInfluentialSelf-citationSerious fungal infections in Portugal
Sabino, R., Veríssimo, C., Brandão, J. C., Martins, C., Alves, D., Pais, C., & Denning, D. W. (2017) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-017-2930-y · Cited by 43
Self-citationBurden of serious fungal infections in Tanzania
Faini, D., Maokola, W., Furrer, H., Hatz, C., Battegay, M., Tanner, M., Denning, D. W., & Letang, E. (2015) · Mycoses · doi:10.1111/myc.12390 · Cited by 42 · cited 8×
“The highest estimated cases were from Nigeria (15,581,400 cases) [62] followed by Kenya with 1,712,676 cases [75], with Senegal, Uganda and Tanzania reporting 1,523,700, 1,300,000 and 420,000 cases respectively [78,122,133].”
BackgroundInfluentialSelf-citationFaria‐Ramos, I., Neves-Maia, J., Ricardo, E., Santos‐Antunes, J., Silva, A. T., Costa‐de‐Oliveira, S., Cantón, R., Rodrigues, A. G., & Pina‐Vaz, C. (2015) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-015-2471-1 · Cited by 41
Estimating the burden of fungal disease in Vietnam
Beardsley, J., Denning, D. W., Châu, N. V. V., Yen, N. T. B., Crump, J. A., & Day, J. (2015) · Mycoses · doi:10.1111/myc.12382 · Cited by 40
Self-citationPrevalence and causative fungal species of tinea capitis among schoolchildren in Gabon
Hogewoning, A. A., Adégnika, A. A., Bavinck, J. N. B., Yazdanbakhsh, M., Kremsner, P. G., van der Raaij-Helmer, E. M. H., Staats, C. C. G., Willemze, R., & Lavrijsen, A. P. M. (2010) · Mycoses · doi:10.1111/j.1439-0507.2010.01923.x · Cited by 39
Burden of fungal infections in Senegal
Badiane, A. S., Ndiaye, D., & Denning, D. W. (2015) · Mycoses · doi:10.1111/myc.12381 · Cited by 39 · cited 6×
“For Jamaica and Senegal no estimate of the burden of invasive aspergillosis was possible.”
BackgroundInfluentialSelf-citationBurden of serious fungal infections in Nepal
Khwakhali, U. S., & Denning, D. W. (2015) · Mycoses · doi:10.1111/myc.12393 · Cited by 38 · cited 7×
“By 2014, Nepal had 7,380,000 women aged between 15 and 49 years.”
BackgroundInfluentialSelf-citationSurvey of aspergillosis in non-neutropenic patients in Swiss teaching hospitals
Garbino, J., Fluckiger, U., Elzi, L., Imhof, A., Bille, J., & Zimmerli, S. (2011) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2010.03402.x · Cited by 37 · cited 1×
“Other lower risk patients include those with COPD [4], high dose corticosteroid treatment [101], lung cancer [102], liver cirrhosis [103,104], renal and liver transplantation [105], diabetes mellitus [106] and sepsis, especially in the ICU setting [107].”
BackgroundTinea capitis among children at one suburban primary school in the City of Maputo, Mozambique
Sidat, M., Correia, D., & Buene, T. P. (2007) · Revista da Sociedade Brasileira de Medicina Tropical · doi:10.1590/s0037-86822007000400020 · Cited by 36
Frequency of familial occurrence in 164 patients with allergic bronchopulmonary aspergillosis
Shah, A., Kala, J., Sahay, S., & Panjabi, C. (2008) · Annals of Allergy, Asthma & Immunology · doi:10.1016/s1081-1206(10)60311-0 · Cited by 36 · cited 1×
“Prevalence primarily reflects the adult asthma prevalence per country, as ABPA in children is rare, although reported [144].”
BackgroundEstimated burden of fungal infections in Kenya
Guto, J. A., Bii, C. C., & Denning, D. W. (2016) · The Journal of Infection in Developing Countries · doi:10.3855/jidc.7614 · Cited by 36 · cited 8×
“2 40% of new AIDS cases in children and 10% in adults Kenya [75] 17,000 43.”
BackgroundInfluentialSelf-citationLópez‐Medrano, F., Fernández‐Ruiz, M., Silva, J. T., Carver, P. L., van Delden, C., Merino, E., Pérez‐Sáez, M. J., Montero, M., Coussement, J., Mazzolin, M. D. A., et al. (2017) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2017.06.016 · Cited by 36
Aquino, V. R., Nagel, F., Andreolla, H. F., de-Paris, F., Xavier, M. O., Goldani, L. Z., Denning, D. W., & Pasqualotto, A. C. (2012) · Mycopathologia · doi:10.1007/s11046-012-9531-1 · Cited by 35
Self-citationIncidence and predictors of invasive candidiasis associated with candidaemia in children
Festekjian, A., & Neely, M. N. (2009) · Mycoses · doi:10.1111/j.1439-0507.2009.01785.x · Cited by 35
An estimate of the burden of serious fungal diseases in Greece
Gamaletsou, M. N., Drogari‐Apiranthitou, M., Denning, D. W., & Sipsas, N. V. (2016) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-016-2642-8 · Cited by 34 · cited 7×
“0 Data from retrospective study in 2014 Greece [72] 112 1.”
BackgroundInfluentialSelf-citationAyanlowo, O. O., Akinkugbe, A., Oladele, R. O., & Balogun, M. R. (2014) · Journal of Public Health in Africa · doi:10.4081/jphia.2014.349 · Cited by 33
Self-citationDenis, B., Guiguet, M., de Castro, N., Mechaï, F., Revest, M., Melica, G., Costagliola, D., & Lortholary, O. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ492 · Cited by 33
Burden of fungal infections in Algeria
Chekiri-Talbi, M., & Denning, D. W. (2017) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-017-2917-8 · Cited by 33 · cited 6×
“Algeria is the only North Africa country that has estimated the burden of the disease and they reported 4265 cases [64].”
BackgroundInfluentialSelf-citationBurden of fungal disease in Ireland
Dorgan, E., Denning, D. W., & McMullan, R. (2015) · Journal of Medical Microbiology · doi:10.1099/jmm.0.000020 · Cited by 32 · cited 8×
“There were 1700 voluntary laboratory reports of candidaemia in 2013 in England, Wales and Northern Ireland.”
BackgroundInfluentialSelf-citationSerious fungal infections in the Philippines
Batac, M. C. F. R., & Denning, D. W. (2017) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-017-2918-7 · Cited by 32 · cited 8×
“2 Nigeria [62] 120,747 78 Philippines [93] 77,172 78 Pakistan [53] 72,438 70 Vietnam [120] 55,509 61 Dominican Republic [69] 1374 55 Uganda [122] 18,000 46 Bangladesh [65] 20,720 41 Kenya [75] 12,927 32 Thailand [55] 19,044 29.”
BackgroundInfluentialSelf-citationDermatophytomycoses in children in rural Kenya: the impact of primary health care
Schmeller, W., Baumgartner, S., & Dzikus, A. (1997) · Mycoses · doi:10.1111/j.1439-0507.1997.tb00171.x · Cited by 31
Tinea capitis in schoolchildren in a rural area in southern E thiopia
Leiva-Salinas, M. D. C., Marín-Cabañas, I., Betlloch, I., Tesfasmariam, A., Reyes, F., Belinchón, I., & Ramos, J. M. (2014) · International Journal of Dermatology · doi:10.1111/ijd.12691 · Cited by 31
Burden of serious fungal infections in Bangladesh
Gugnani, H. C., Denning, D. W., Rahim, R., Sadat, A., Belal, M., & Mahbub, M. S. (2017) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-017-2921-z · Cited by 31 · cited 3×
“5% of asthma Bangladesh [123] 90,262 56 2.”
BackgroundInfluentialSelf-citationBurden of serious fungal infections in Guatemala
Medina, N., Samayoa, B. E., Lau-Bonilla, D., Denning, D. W., Herrera, R., Mercado, D., Guzmán, B., Pérez, J. C., & Arathoon, E. (2017) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-017-2920-0 · Cited by 31 · cited 5×
“98 per 100,000 of intra-abdominal peritonitis Greece [72] 541 5 No local incidence data Guatemala [73] 772 5 No local incidence data Jamaica [74] 136 5 5.”
BackgroundInfluentialSelf-citationBurden of serious fungal infections in Trinidad and Tobago
Denning, D. W., & Gugnani, H. C. (2015) · Mycoses · doi:10.1111/myc.12394 · Cited by 29 · cited 7×
“0 10% in HIV with CD4 < 200 Trinidad and Tobago [79] 400 30.”
BackgroundInfluentialSelf-citationRecent Advances in the Diagnosis of Pneumocystis Pneumonia
Song, Y., Ren, Y., Wang, X., & Li, R. (2016) · Medical Mycology Journal · doi:10.3314/mmj.16-00019 · Cited by 29
Fungal keratitis in the Republic of Ireland
Farrell, S., McElnea, E., Moran, S., Knowles, S., & Murphy, C. C. (2017) · Eye · doi:10.1038/eye.2017.82 · Cited by 28
Invasive aspergillosis in patients with underlying liver cirrhosis: a prospective cohort study
Prattes, J., Hoenigl, M., Krause, R., Buzina, W., Valentin, T., Reischies, F., Koidl, C., & Zollner‐Schwetz, I. (2017) · Medical Mycology · doi:10.1093/mmy/myx011 · Cited by 28 · cited 1×
“Other lower risk patients include those with COPD [4], high dose corticosteroid treatment [101], lung cancer [102], liver cirrhosis [103,104], renal and liver transplantation [105], diabetes mellitus [106] and sepsis, especially in the ICU setting [107].”
BackgroundThe burden of fungal disease in Denmark
Mortensen, K. L., Denning, D. W., & Arendrup, M. C. (2015) · Mycoses · doi:10.1111/myc.12383 · Cited by 27 · cited 7×
“[58] estimated the burden of invasive aspergillosis (IA) and other fungal diseases in Denmark.”
BackgroundMethodInfluentialSelf-citationBurden of serious fungal infections in the Dominican Republic
Gugnani, H. C. C., & Denning, D. W. (2015) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2015.04.026 · Cited by 26 · cited 9×
“2 Nigeria [62] 120,747 78 Philippines [93] 77,172 78 Pakistan [53] 72,438 70 Vietnam [120] 55,509 61 Dominican Republic [69] 1374 55 Uganda [122] 18,000 46 Bangladesh [65] 20,720 41 Kenya [75] 12,927 32 Thailand [55] 19,044 29.”
BackgroundInfluentialSelf-citationBurden of serious fungal infections in Belgium
Lagrou, K., Maertens, J. A., Even, E. V., & Denning, D. W. (2015) · Mycoses · doi:10.1111/myc.12389 · Cited by 25 · cited 5×
“United Kingdom [19] 413,724 654 Trinidad and Tobago [79] 4608 344 Dominican Republic [69] 33,197 329 Ecuador [70] 45,183 311 Brazil [52] 599,283 288 Belgium [66] 30,402 273 Greece [72] 27,744 256 Jamaica [74] 6753 248 Egypt [71] 176,661 214”
BackgroundInfluentialSelf-citationSobel, J. D. (2014) · Medicine · doi:10.1016/j.mpmed.2014.04.006 · Cited by 24
Serious fungal infections in Ecuador
Zurita, J., Denning, D. W., Paz-y-Miño, A., Solís, M. B., & Arias, L. M. (2017) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-017-2928-5 · Cited by 23 · cited 7×
“4/100,000 from previously published studies Ecuador [70] 535 3.”
BackgroundInfluentialSelf-citationSerious fungal infections in Chile
Álvarez, E., & Denning, D. W. (2017) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-017-2925-8 · Cited by 23 · cited 3×
“Germany [82] 163,131 203 Spain [60] 93,044 198 France [85] 124,678 189 Ireland [61] 1 1,675 182 Hungary [56] 17,330 175 Philippines [93] 159,869 162 Russia [59] 231,000 161 Portugal [91] 16,614 159 Denmark [58] 7793 139 Chile [67] 22,300 127 Austria [89] 9949 121 Algeria [64] 41,329 102 Peru [77] 29,638 95 Senegal [13…”
BackgroundSelf-citationDiagnosis and Management of Pneumocystis Pneumonia in Resource-poor Settings
Oladele, R. O., Otu, A. A., Richardson, M. D., & Denning, D. W. (2018) · Journal of Health Care for the Poor and Underserved · doi:10.1353/hpu.2018.0010 · Cited by 23
Self-citationBurden of serious fungal infections in the Czech Republic
Chrdle, A., Mallátová, N., Vašáková, M., Haber, J., & Denning, D. W. (2015) · Mycoses · doi:10.1111/myc.12384 · Cited by 22 · cited 6×
“5% of asthma Czech Republic [68] 4739 45 2.”
BackgroundInfluentialSelf-citation(2014) · PubMed · Cited by 22
Burden of serious fungal diseases in Hungary
Sinkó, J., Sulyok, M., & Denning, D. W. (2015) · Mycoses · doi:10.1111/myc.12385 · Cited by 21 · cited 7×
“On the other hand, the lowest PCP burdens have been reported in Denmark (2), Hungary (5), Qatar (15) and Israel (26).”
BackgroundInfluentialSelf-citationBurden of serious fungal infections in Ukraine
Osmanov, A., & Denning, D. W. (2015) · Mycoses · doi:10.1111/myc.12409 · Cited by 20 · cited 8×
“Up to 28,447 Patients with ABPA and 37,491 with SAFS in Ukraine From the estimates by Osmanov et al. [80], 28,447 patients were estimated to have ABPA and 37,491 with SAFS in Ukraine.”
BackgroundInfluentialSelf-citationSerious fungal infections in Peru
Bustamante, B., Denning, D. W., & Campos, P. E. (2017) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-017-2924-9 · Cited by 20 · cited 5×
“8 Peru [77] 3593 11 Guatemala [73] 1484 9.”
BackgroundInfluentialSelf-citationSerious fungal infections in Korea
Huh, K., Ha, Y. E., Denning, D. W., & Peck, K. R. (2017) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-017-2923-x · Cited by 19 · cited 8×
“36 Based on cases seen at a tertiary government hospital in the national capital region in 2015 Korea [84] 29 0.”
BackgroundInfluentialSelf-citation(2017) · PubMed · Cited by 19
Estimating the Burden of Fungal Diseases in Israel.
Ben, R., & Denning, D. W. (2015) · PubMed · Cited by 18
Self-citationDiongue, K., Diallo, M., Ndiaye, M., et al. (2016) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2016.08.003 · Cited by 17
Invasive Aspergillosis in Hematological Patients
Kimura, S.-I. (2016) · Medical Mycology Journal · doi:10.3314/mmj.57.j77 · Cited by 14
Rapidly progressive invasive pulmonary aspergillosis in a diabetic man
Komase, Y., Kunishima, H., Yamaguchi, H., 池原, 瑞., Yamamoto, T., & Shinagawa, T. (2007) · Journal of Infection and Chemotherapy · doi:10.1007/s10156-006-0481-8 · Cited by 13 · cited 1×
“Other lower risk patients include those with COPD [4], high dose corticosteroid treatment [101], lung cancer [102], liver cirrhosis [103,104], renal and liver transplantation [105], diabetes mellitus [106] and sepsis, especially in the ICU setting [107].”
BackgroundEstimated Burden of Serious Fungal Infections in Jamaica
Gugnani, H. C., & Denning, D. W. (2015) · West Indian Medical Journal · doi:10.7727/wimj.2014.204 · Cited by 13 · cited 5×
“1 Jamaica [74] 82 3 Germany [82] 2320 2.”
BackgroundInfluentialSelf-citationSerious fungal diseases in the Republic of Uzbekistan
Tilavberdiev, S. A., Denning, D. W., & Климко, Н. Н. (2017) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-017-2926-7 · Cited by 13 · cited 5×
“2 22% of new AIDS Uzbekistan [63] 165 5.”
BackgroundInfluentialSelf-citationEpidemiology of Fungal Keratitis in North Vietnam
Nhung, P. H. (2012) · Journal of Clinical & Experimental Ophthalmology · doi:10.4172/2155-9570.1000238 · Cited by 12 · cited 1×
“00 Based on previous Vietnamese study reporting a rate of 7 per 100,000 [160]”
BackgroundDermatophytic Infection of the Scalp in the Region of Butare (Rwanda)
Buginco, C. (1983) · International Journal of Dermatology · doi:10.1111/j.1365-4362.1983.tb03324.x · Cited by 10
OECD (2011) · Health at a glance · doi:10.1787/g2g14e38-en · Cited by 9
Special considerations for the diagnosis and treatment of invasive pulmonary aspergillosis
McCarthy, M. W., & Walsh, T. J. (2017) · Expert Review of Respiratory Medicine · doi:10.1080/17476348.2017.1340835 · Cited by 8 · cited 1×
“In these patients, with impaired immune function, Aspergillus growth in the lung leads to tissue destruction, angio-invasion, a septic state in its final phase and sometimes haemoptysis [98].”
BackgroundBurden of serious fungal infections in Germany
Ruhnke, M., Groll, A. H., Ullmann, A. J., & Denning, D. W. (2014) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2014.03.1004 · Cited by 2
Self-citationTartière, D., Séguin, P., Mallédant, Y., et al. (2012) · The International Journal of Tuberculosis and Lung Disease · doi:10.5588/ijtld.12.0051 · Cited by 2 · cited 1×
“Other lower risk patients include those with COPD [4], high dose corticosteroid treatment [101], lung cancer [102], liver cirrhosis [103,104], renal and liver transplantation [105], diabetes mellitus [106] and sepsis, especially in the ICU setting [107].”
Background(2016) · PubMed · Cited by 1
Avoidable admissions: respiratory diseases
OECD (2009) · Health at a glance · doi:10.1787/health_glance-2009-48-en · Cited by 1
Research works printed but not linked: 6
- Denning, 2013, Global fungal Burden, Mycoses, 56, 13
- The Fungal Infection Trust (2011, January 18). How common are fungal diseases?. Proceedings of the Fungal Research Trust 20th Anniversary Meeting, London, UK. Available online: http://www.fungalinfectiontrust.org/wp-content/uploads/2015/12/How-Common-are-Fungal-Diseases-v12.2.pdf.
- Jayasekera, 2013, The burden of serious fungal infections in Sri Lanka, Mycoses, 56, 103
- Gugnani, 2017, Burden of serious fungal infections in Bangladesh, Eur. J. Clin. Microbiol. Infect. Dis., 36, 965, 10.1007/s10096-017-2921-z · DOI · Paper page
- Samayoa, B., Isern, V., Serra, L., Rivera, B.E., Nikiforov, M., Arathoon, E., Samayoa, C., Vallès, X., Prieto, L., and Álvarez, C. (2010, January 18–23). Preliminary results of a prospective cohort of HIV+ patients in Guatemala. Proceedings of the XVIII International AIDS Conference, Vienna, Austria.
- Gopinathan, 2002, The Epidemiological Features and Laboratory Results of Fungal Keratitis, Eye, 21, 555
Cited by
Global incidence and mortality of severe fungal disease
Denning, D. W. (2024) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(23)00692-8 · Cited by 1,640
Self-citationTackling the emerging threat of antifungal resistance to human health
Fisher, M. C., Alastruey-Izquierdo, A., Berman, J., Bicanic, T., Bignell, E. M., Bowyer, P., Bromley, M., Brüggemann, R., Garber, G., Cornely, O. A., et al. (2022) · Nature Reviews Microbiology · doi:10.1038/s41579-022-00720-1 · Cited by 1,179
Global Epidemiology of Mucormycosis
Prakash, H., & Chakrabarti, A. (2019) · Journal of Fungi · doi:10.3390/jof5010026 · Cited by 938
“After the inclusion of Indian data, the estimate of mucormycosis rose to 910,000 cases globally [23,24].”
BackgroundPfaller, M. A., Diekema, D. J., Turnidge, J. D., Castanheira, M., & Jones, R. N. (2019) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofy358 · Cited by 825
“The burden of invasive fungal infections (IFIs) for patients and health care systems is difficult to measure [2, 12]; however, it is well recognized that IFIs are associated with high morbidity and mortality rates and elevated health care costs.”
BackgroundThreats Posed by the Fungal Kingdom to Humans, Wildlife, and Agriculture
Fisher, M. C., Gurr, S. J., Cuomo, C. A., Blehert, D. S., Jin, H., Stukenbrock, E. H., Stajich, J. E., Kahmann, R., Boone, C., Denning, D. W., et al. (2020) · mBio · doi:10.1128/mbio.00449-20 · Cited by 536
Self-citation
Metadata
- Authors
- Bongomin, F., Gago, S., Oladele, R., & Denning, D.
- Affiliations
- University of Manchester (GB)
- Corresponding author
- Denning, David
- Venue
- Journal of Fungi
- Publisher
- MDPI AG
- Published
- 2017-10-18
- Volume
- 3
- Issue
- 4
- Pages
- 57
- ISSN
- 2309-608X (ISSN-L)
- PMC
- PMC5753159
- OpenAlex
- W2767031614
- Semantic Scholar
- a31bc4c8c2356520b0818d41b5c4a2e2091b6f32
- Cited by
- 2,953
- References
- 192
- Citations by year
- 2026: 280 · 2025: 388 · 2024: 518 · 2023: 436 · 2022: 427 · 2021: 370 · 2020: 307 · 2019: 156 · 2018: 67 · 2017: 2
- FWCI
- 22.27
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Journal of Fungi (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Research Explorer (The University of Manchester) (publishedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC/P002390/1)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Health Sciences › Medicine › Infectious Diseases › Fungal Infections and Studies
- Health Sciences › Medicine › Dermatology › Nail Diseases and Treatments
- Keywords
- fungal infection, disease burden estimation, prevalence, chronic pulmonary aspergillosis, cryptococcal meningitis, invasive candidiasis, Pneumocystis carinii pneumonia, invasive aspergillosis, disseminated histoplasmosis, fungal asthma, fungal keratitis, HIV/AIDS, antifungal therapy, estimation accuracy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.